The unit's licence was cancelled in June after several women in Kota, Rajasthan, died allegedly due to spurious oxytocin injections supplied by the company's Punjab unit.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/agUXoKF
via IFTTT
-
Lilly's Mounjaro has rapidly become the second-highest selling drug in India's pharmaceutical market, achieving ₹233 crore in sales ...
-
India's Syngene International has agreed to acquire its first biologics facility in the U.S. from Emergent Manufacturing for $36.5 milli...
-
The Indian Council of Medical Research has licensed three new biomedical technologies. These innovations aim to advance cancer treatment and...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2026
(586)
-
▼
August
(78)
- Sun Pharma to extend MFN pricing to US state Medic...
- Delhi HC orders forensic audit of Fortis, Singh br...
- Sun Pharma among 9 pharmaceutical firms to lower d...
- Zydus’ Saroglitazar meets primary goal in global P...
- India seeks easier pharma access in Brazil, pushes...
- Healthcare ranks second in private credit deals as...
- Jharkhand on high alert over Swine Flu; Health Min...
- Park Medi World to expand hospital network across ...
- Amrutanjan Health plans to set up 1 lakh direct ch...
- Is longevity the new flex? Why the new wellness st...
- Cipla Pharma license cancellation: FDA withdraws o...
- Drugmakers may bear sole responsibility for overpr...
- Jubilant Generics receives show-cause notice deman...
- Yatharth Hospitals draws interest from Aster, Adve...
- Demand for vaccines surges as H1N1, other influenz...
- Convening India's brightest minds: The Bharat Life...
- Piramal Alternatives invests Rs 215 crore in Kolor...
- Kedaara pumps $200m into ortho support wear maker ...
- Grip strength, gait may soon measure biological li...
- Kedaara Capital bets on India’s orthopaedic market...
- Biocon arm gets Japan nod for cancer drug pegfilgr...
- Govt eases loan licence requirement for 'outsource...
- DRL, Emcure get approval to make breakthrough HIV ...
- Adani Group to set up 2,000-bed hospital in Bengal...
- USFDA ends inspection of Aurobindo Pharma arm's fa...
- Indian pharma has little reason to fear Trump
- Udan vs Udaan: Delhi court restrains pharmaceutica...
- Govt tightens rules on combinations containing 2 c...
- Zydus Lifesciences gets USFDA nod for generic asco...
- Medical devices industry needs to focus more on lo...
- Delhi High Court rules in favour of Dr Reddy's Lab...
- Lupin arm to commercialise YUVEZZI eye drop across...
- Moderna, Merck breakthrough could usher in wave of...
- Pharma giant Cipla completes merger with wholly-ow...
- Lord’s Mark Industries announces license for biome...
- Apollo Hospitals extends services to all seven day...
- Manipal Health Enterprises to acquire Kinder Women...
- Healthcare delivery capital-intensive, hospital ta...
- India's pharma sector must shift from cost competi...
- Lupin gets USFDA nod for generic tablets to treat ...
- Aurobindo Pharma’s Raleigh plant gets 'Voluntary A...
- India plans national sports medicine framework ahe...
- In private healthcare's rise, price points are a b...
- AI could cut doctors' paperwork burden as global h...
- Thermo Fisher finds India the perfect lab; lab equ...
- Aurobindo Pharma arm Eugia Pharma's Telangana unit...
- Gland Pharma appoints Dr Reddy’s senior executive ...
- Delhi HC backs Zydus in trademark row
- Narayana Health, NDB sign pact to share smart hosp...
- Govt tightens drug quality net, initiates 950 acti...
- Maharashtra FDA cracks down on Ayurvedic drug make...
- Regulator mandates full review of globally unappro...
- US-based Amgen to open science and innovation cent...
- Philips India sees India emerging as global R&D, A...
- Doctors' safety alert led to Sun Pharma eye drop r...
- Medical devices are not pharma products, companies...
- Wockhardt takes on India’s superbug crisis with ne...
- Warburg set to buy Seacod-maker Universal NutriSci...
- Gland Pharma inks strategic CDMO deal with global ...
- IIT Guwahati develops 'E-Eye' for rapid detection ...
- Govt plans new drugs law to overhaul pharma, medic...
- Emcure Pharma net profit up 36% at Rs 292 crore
- KKR deepens India healthcare bet with $1.39 billio...
- Centre to bar drugmakers from selling mislabelled,...
- KKR buys Medicover’s India hospitals business
- KKR to acquire Medicover India in $1.5 billion deal
- Delhi HC seeks response on Natco's patent challeng...
- Cipla, Rocket India announce Rs 300 crore expansio...
- IPA seeks to regularise 'legacy' drugs
- Dr Reddy's Laboratories launches generic Sugammade...
- India pharma sector to miss 2030 sales target amid...
- Private equity firm Creador in talks to buy into g...
- Two-wheeled road ambulance to run from October 1, ...
- Losing weight fast on GLP-1 drugs? Your hair could...
- India's Second Leapfrog: From sick-care to AI-nati...
- GLP-1 demand stirs up hunger for obesity care talent
- Jackson Labs' Baddi drug manufacturing licence res...
- Sun Pharma recalls eye drops in India after contam...
-
▼
August
(78)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment